After US approval, Japan OKs Leqembi, its first Alzheimer’s drug, developed by Eisai and Biogen

After US approval, Japan OKs Leqembi, its first Alzheimer’s drug, developed by Eisai and Biogen

Upworthy

Published

Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.

#leqembi

Full Article